Page 2 Heart Failure Remote Monitoring Evidence From the Retrospective Evaluation of a Real World Remote Monitoring Program

consistent until the end of the 4-month program (HR=0.74, 95% CI 0.54-1.02, P=.06). The program
was also associated with lower mortality rates at the end of the 4-month program: relative risk (RR)

=0.33, 95% 0.11-0.97, P=.04). Additional 8-months follow-up following program completion did not
show residual beneficial effects of the CCCP program on mortality (HR=0.64, 95% 0.34-1.21, P=.17) or
hospitalizations (HR=1.12, 95% 0.90-1.41, P=.31).
Conclusions: CCCP was associated with significantly lower hospitalization rates up to 90 days and

significantly lower mortality rates over 120 days of the program. However, these effects did not persist
beyond the 120-day program duration.

J Med Internet Res 2015; 17(4):e101)

1 Partners Healthcare Center for Connected Health, Connected Health Innovation, Boston, MA, United
States
2 Massachusetts General Hospital, Boston, MA, United States
3 Harvard Medical School, Boston, MA, United States
4 Northeastern University, Boston, MA, United States
*these authors contributed equally
Corresponding Author:
Stephen Agboola, MD, MPH
Partners Healthcare Center for Connected Health
Connected Health Innovation

25 New Chardon St.
Suite 300
Boston, MA, 02128
United States
Phone: 1 617 643 0291
Fax: 1 617 228 4619
Email: sagboola [at] mgh.harvard.edu

pg. 2